INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "ALPHA-PARTICLE RADIONUCLIDE-ANTIBODY CONJUGATES FOR TREATMENT OF SOLID TUMORS"

GENEVA, July 21 -- THE JOHNS HOPKINS UNIVERSITY (3400 N. Charles StreetBaltimore, Maryland 21218) filed a patent application (PCT/US2025/010658) for "ALPHA-PARTICLE RADIONUCLIDE-ANTIBODY CONJUGATES FOR TREATMENT OF SOLID TUMORS" on Jan 08, 2025. With publication no. WO/2025/151464, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SOFOU, Stavroula (c/o The Johns Hopkins University3400 North Charles StreetBaltimore, Maryland 21218)

Abstract: Compositions comprising one or more targeting (or high affinity) radionuclide-ant...